Opus Genetics, Inc. (IRD) has 21 open-market insider trades by 9 insiders since 2024. Over the last six months insiders net sold $10.4M. The most active filer is George Magrath, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Dir | — | 2 | $16.0M | 2026-05-18 |
| Foundation Fighting Blindness, Inc. | Dir | — | 1 | $2.8M | 2026-09-30 |
| George Magrath | CEO | — | 5 | $623K | 2026-09-09 |
| Cam Gallagher | Dir | — | 1 | $324K | 2026-09-08 |
| Ashwath Jayagopal | — | — | 2 | $77K | 2026-04-23 |
| Joseph K. Schachle | COO | — | 3 | $77K | 2026-07-23 |
| Benjamin R. Yerxa | Pres | — | 3 | $71K | 2026-07-23 |
| Robert E. Gagnon | CFO | — | 2 | $64K | 2026-09-03 |
| Rabourn Amy Zaremba | — | — | 2 | $38K | 2026-04-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Foundation Fighting Blindness, Inc. | Director | Sell | $2.8M | 2026-09-30 |
| Robert E. Gagnon | CFO | Sell | $127K | 2026-09-03 |
| George Magrath | CEO | Sell | $28K | 2026-07-23 |
| Joseph K. Schachle | COO | Sell | $14K | 2026-07-23 |
| Robert E. Gagnon | CFO | Sell | $23K | 2026-07-23 |
| Benjamin R. Yerxa | President | Sell | $22K | 2026-07-23 |
Companies that share insiders with IRD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | $7.4M | 2026-05-18 |
| Rabourn Amy Zaremba | — | Sell | $9K | 2026-04-23 |
| Benjamin R. Yerxa | President | Sell | $39K | 2026-04-23 |
| George Magrath | CEO | Sell | $50K | 2026-04-23 |
| Ashwath Jayagopal | — | Sell | $39K | 2026-04-23 |
| Robert E. Gagnon | CFO | Sell | $41K | 2026-04-23 |
| Joseph K. Schachle | COO | Sell | $25K | 2026-04-23 |
| Rabourn Amy Zaremba | — | Sell | $30K | 2026-03-16 |
| George Magrath | CEO | Sell | $255K | 2026-03-16 |